Company / Capital Expenditures
Cyclerion Therapeutics, Inc. Capital Expenditures History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2022
5-year range
$0 / $1.5M
FY2019-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7M to $0 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capital expenditures decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.5M | -77.9% |
| FY2020 | $6.9M | +100.3% |
| FY2019 | $3.4M | - |
As of FY2022 · SEC 10-K Annual Filings · Updated Jun 24, 2026